Publication|Articles|January 18, 2025

Peers & Perspectives in Oncology

  • January 2025
  • Volume 03
  • Issue 01
  • Pages: 52

Roundtable Roundup: Lung Cancer Molecular Testing and ALK-Targeted Treatment

Fact checked by: Dylann Bailey

In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options for a patient with metastatic non–small cell lung cancer (NSCLC), with participants.

CASE SUMMARY

History of Present Illness

  • A 53-year-old Asian American woman presented to her primary care physician with complaints of a persistent, productive cough mixed with scant amounts of blood and associated with chest discomfort upon deep inspiration.
  • She denied fever, night sweats, headache, or recent upper respiratory infection.

Medical, Family, and Social History

  • The patient had 1 pregnancy and delivered once.
  • Negative medical surgical history; no prescription medication use
  • Never smoker; employed full-time; 16-year-old son in high school
  • Caregiver for elderly mother
  • No family history of malignancy; occasional use of alcohol
  • COVID-19 vaccine: up to date

Focused Physical Examination

  • ECOG performance status: 0
  • Neurological: alert and oriented times 3; no signs of neurological compromise; mental status intact
  • Pulmonary: diminished breath sounds on auscultation over the posterior, right, upper lung field; scattered crackles and expiratory wheezes
  • Remainder of physical examination: unremarkable

Initial Diagnostic Assessment

  • Chest x-ray: right, upper lobe opacity and mediastinal enlargement
  • Patient is referred to a thoracic oncologist for further evaluation.
  • CT of chest, abdomen, and pelvis: multiple, peripheral nodules in right upper lobe, the largest measuring 3.7 cm × 3.4 cm in diameter with ipsilateral mediastinal lymphadenopathy of varying nodal size between 2.2 cm and 2.8 cm.
  • No evidence of hepatic involvement
  • Staging MRI of brain: discreet intracranial lesions in the parietal (2.6 cm) and frontal (1.2 cm) lobes
  • T2aN2M1b (metastatic)

Diagnostic Procedure

  • Patient underwent endobronchial ultrasound-guided transbronchial needle aspiration and endoscopic ultrasound-guided fine-needle aspiration of lung and mediastinal lymph nodes.

Histopathology

  • Tumor cell clusters with high nucleus to cytoplasmic ratio; pleomorphic nuclei and granular chromatin; acinar structure with signet-ring cell morphology consistent with adenocarcinoma; short axis diameter of mediastinal node specimen: 2.1 cm
  • Immunohistochemistry: TTF-1+, napsin A+; CEA+

CASE UPDATE

• Tissue next-generation sequencing (NGS) molecular profile report: EML4::ALK fusion

• Remainder of the broad-based panel: negative


Latest CME